{"id":"depo-medroxyprogesterone-acetate","safety":{"commonSideEffects":[{"rate":"40-50","effect":"Irregular bleeding or amenorrhea"},{"rate":"2-3 kg average","effect":"Weight gain"},{"rate":"5-10","effect":"Headache"},{"rate":"5-10","effect":"Breast tenderness"},{"rate":"5","effect":"Mood changes"},{"rate":"null","effect":"Delayed return to fertility"}]},"_chembl":{"chemblId":"CHEMBL287148","moleculeType":"Small molecule","molecularWeight":"386.53"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"DMPA acts as a long-acting reversible contraceptive by binding to progesterone receptors in the hypothalamus and pituitary gland, inhibiting the luteinizing hormone (LH) surge required for ovulation. It also alters the endometrium and increases cervical mucus viscosity, creating a hostile environment for sperm. The intramuscular or subcutaneous formulation provides contraceptive efficacy for approximately 12-13 weeks per injection.","oneSentence":"Depo-medroxyprogesterone acetate (DMPA) is a synthetic progestin that prevents pregnancy by suppressing ovulation and thickening cervical mucus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:32:17.560Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception (prevention of pregnancy)"},{"name":"Management of endometriosis-related pain"}]},"trialDetails":[{"nctId":"NCT06665997","phase":"PHASE4","title":"Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2025-06-26","conditions":"Sickle Cell Disease (SCD), Vaso-Occlusive Pain Episode in Sickle Cell Disease","enrollment":65},{"nctId":"NCT05726903","phase":"PHASE4","title":"Counseling Among Gender Diverse Adolescents Who Use Depot Medroxyprogesterone","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2022-12-06","conditions":"Gender Dysphoria, Adolescent","enrollment":35},{"nctId":"NCT06816901","phase":"PHASE4","title":"Measuring Lactation Initiation After Early Postpartum Injectable Progestin (DMPA) Use Among Women in Dhanusha District of Nepal: A Pilot Study","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2025-03-26","conditions":"Postpartum Contraception, Depot Medroxyprogesterone Acetate, Lactation","enrollment":40},{"nctId":"NCT05044962","phase":"NA","title":"Kuwa Free! - Live Free!","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2021-11-26","conditions":"HIV Infections, Contraception, Drug-drug Interaction","enrollment":700},{"nctId":"NCT04669678","phase":"PHASE4","title":"Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South Africa","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2021-11-17","conditions":"HIV Infections, Contraception, Drug-drug Interaction","enrollment":110},{"nctId":"NCT05760144","phase":"EARLY_PHASE1","title":"Endometrial Biopsy in Progestin Contraceptive Users","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2023-07-01","conditions":"Contraception","enrollment":52},{"nctId":"NCT02076217","phase":"","title":"Quick Start of Highly Effective Contraception","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2014-02","conditions":"IUD, Contraceptive Implant, Contraception","enrollment":1030},{"nctId":"NCT06145438","phase":"PHASE3","title":"Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery","status":"COMPLETED","sponsor":"Universitas Diponegoro","startDate":"2023-09-04","conditions":"Endometriosis Ovary","enrollment":80},{"nctId":"NCT03660046","phase":"","title":"Contraceptive Hormones, Immunity, and Microbiome Evaluation","status":"COMPLETED","sponsor":"Emory University","startDate":"2018-12-07","conditions":"Hormonal Contraception","enrollment":155},{"nctId":"NCT00830414","phase":"PHASE1","title":"Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-04","conditions":"Healthy","enrollment":124},{"nctId":"NCT03844633","phase":"PHASE4","title":"Postpartum Family Planning","status":"TERMINATED","sponsor":"Ohio State University","startDate":"2019-03-21","conditions":"Delay in Time to Lactogenesis Stage II","enrollment":49},{"nctId":"NCT04682353","phase":"PHASE1","title":"A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2020-12-14","conditions":"Contraception","enrollment":60},{"nctId":"NCT00577122","phase":"PHASE2","title":"Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer","status":"COMPLETED","sponsor":"Indiana University","startDate":"2007-07","conditions":"Estrogen Receptor-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer, Recurrent Breast Cancer","enrollment":30},{"nctId":"NCT05973253","phase":"PHASE2, PHASE3","title":"Evaluation of Efficacy and Safety of Topical 1% Medroxyprogesterone in the Corneal Epithelium Healing After PRK","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2023-04-21","conditions":"Photorefractive Keratectomy","enrollment":74},{"nctId":"NCT04910711","phase":"PHASE4","title":"Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIV","status":"UNKNOWN","sponsor":"Botswana Harvard AIDS Institute Partnership","startDate":"2021-10-21","conditions":"Human Immunodeficiency Virus, Contraception, ART","enrollment":140},{"nctId":"NCT03916328","phase":"PHASE4","title":"BONE: STAR (Switching to TAF Based Anti-Retroviral Therapy) Study","status":"UNKNOWN","sponsor":"MU-JHU CARE","startDate":"2019-12-03","conditions":"Bone Loss","enrollment":330},{"nctId":"NCT05742503","phase":"","title":"Progesterone Containing Contraceptive Methods on Endogenous Progesterone Level","status":"COMPLETED","sponsor":"Tanta University","startDate":"2021-03-30","conditions":"Progesterone, Contraceptive Methods","enrollment":80},{"nctId":"NCT05491343","phase":"PHASE4","title":"Observation vs Progesterone Treatment for Management of Uterine Arteriovenous Malformation","status":"UNKNOWN","sponsor":"HaEmek Medical Center, Israel","startDate":"2022-08","conditions":"Arteriovenous Malformations","enrollment":28},{"nctId":"NCT01174225","phase":"PHASE4","title":"IUD Insertion Post First Trimester Abortion","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2010-09","conditions":"Contraception","enrollment":534},{"nctId":"NCT03700658","phase":"PHASE1","title":"A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2019-01-15","conditions":"Contraception","enrollment":27},{"nctId":"NCT01873170","phase":"","title":"Quantification of Immune Cells in Women Using Contraception (CHIC II)","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2013-08","conditions":"HIV, Immune Cells (Mucosal and Systemic), Contraception","enrollment":326},{"nctId":"NCT00563576","phase":"NA","title":"Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation","status":"COMPLETED","sponsor":"Columbia University","startDate":"2007-09","conditions":"Metrorrhagia","enrollment":71},{"nctId":"NCT03018249","phase":"EARLY_PHASE1","title":"Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-10-11","conditions":"FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 3 Endometrial Endometrioid Adenocarcinoma","enrollment":50},{"nctId":"NCT03255941","phase":"EARLY_PHASE1","title":"Clinical Study of Depo Provera Comparing Lay Health Workers and Clinically-trained Health Workers","status":"COMPLETED","sponsor":"FHI 360","startDate":"2018-03-19","conditions":"Contraception","enrollment":460},{"nctId":"NCT02357368","phase":"PHASE4","title":"Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk","status":"COMPLETED","sponsor":"Lisa Haddad","startDate":"2015-02","conditions":"HIV, Contraception","enrollment":59},{"nctId":"NCT02509767","phase":"PHASE4","title":"Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned Parenthood","status":"COMPLETED","sponsor":"Planned Parenthood Federation of America","startDate":"2015-08","conditions":"Contraception","enrollment":401},{"nctId":"NCT01019369","phase":"NA","title":"Study of Self or Clinic Administration of DepoProvera","status":"COMPLETED","sponsor":"Carolyn L. Westhoff","startDate":"2010-03","conditions":"Contraception","enrollment":132},{"nctId":"NCT02456584","phase":"PHASE1","title":"Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods","status":"COMPLETED","sponsor":"FHI 360","startDate":"2015-09","conditions":"Contraception","enrollment":42},{"nctId":"NCT00437658","phase":"PHASE2","title":"Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis","status":"COMPLETED","sponsor":"AbbVie","startDate":"2006-12-11","conditions":"Endometriosis","enrollment":252},{"nctId":"NCT01463202","phase":"PHASE4","title":"Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression","status":"COMPLETED","sponsor":"Beatrice Chen","startDate":"2011-11","conditions":"Contraception, Postpartum Depression, Lactation","enrollment":184},{"nctId":"NCT02732418","phase":"PHASE1","title":"Lower Dose Depo Provera® Contraceptive Injection","status":"COMPLETED","sponsor":"FHI 360","startDate":"2016-12-02","conditions":"Contraception","enrollment":60},{"nctId":"NCT03377608","phase":"","title":"Modifiers of Tenofovir in the Female Genital Tract","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2017-11-17","conditions":"HIV/AIDS, Contraception","enrollment":50},{"nctId":"NCT01461824","phase":"PHASE3","title":"Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects","status":"COMPLETED","sponsor":"Nationwide Children's Hospital","startDate":"2011-09","conditions":"Weight Gain, Disorder of Bone Density and Structure, Unspecified, Uterine Bleeding","enrollment":34},{"nctId":"NCT02103660","phase":"PHASE4","title":"Clinical Trial on the Effects of Progestin-based Contraception in the Genital Tract of HIV-infected and Uninfected Women","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2014-04-08","conditions":"HIV, Contraception","enrollment":131},{"nctId":"NCT01299116","phase":"PHASE4","title":"Long-Acting Reversible Contraception","status":"COMPLETED","sponsor":"FHI 360","startDate":"2011-12","conditions":"Contraception","enrollment":916},{"nctId":"NCT02293694","phase":"NA","title":"Sayana® Press Self-injection Study in Malawi","status":"COMPLETED","sponsor":"FHI 360","startDate":"2015-09-17","conditions":"Contraception","enrollment":735},{"nctId":"NCT01356927","phase":"","title":"Same-day Long-acting Reversible Contraception for Medication Abortion","status":"COMPLETED","sponsor":"Boston University","startDate":"2011-05","conditions":"Abortion; Induced","enrollment":40},{"nctId":"NCT02146248","phase":"NA","title":"HSG and Tubal Patency Study","status":"COMPLETED","sponsor":"Jeffrey Jensen","startDate":"2014-05","conditions":"Tubal Patency","enrollment":11},{"nctId":"NCT02335203","phase":"PHASE2","title":"The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy","status":"UNKNOWN","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2015-02","conditions":"Grade 1 Endometrial Endometrioid Adenocarcinoma, Grade 2 Endometrial Endometrioid Adenocarcinoma, Complex Atypical Endometrial Hyperplasia","enrollment":76},{"nctId":"NCT00064025","phase":"PHASE2","title":"Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus","status":"COMPLETED","sponsor":"Gynecologic Oncology Group","startDate":"2004-04","conditions":"Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation","enrollment":75},{"nctId":"NCT01296152","phase":"PHASE2","title":"Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women","status":"COMPLETED","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2011-05","conditions":"HIV-1 Infection","enrollment":25},{"nctId":"NCT01421368","phase":"PHASE1","title":"Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use","status":"COMPLETED","sponsor":"CONRAD","startDate":"2012-03","conditions":"HIV Prevention","enrollment":72},{"nctId":"NCT01056042","phase":"PHASE4","title":"Efficacy of Injectable Contraceptive and Oral Contraceptive Administered After Surgical Treatment of Endometriosis With Pain","status":"COMPLETED","sponsor":"Prince of Songkla University","startDate":"2007-06","conditions":"Endometriosis","enrollment":112},{"nctId":"NCT01148420","phase":"PHASE4","title":"DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding","status":"COMPLETED","sponsor":"Women's Health Care Clinic, Torrance, California","startDate":"2009-01","conditions":"Dysfunctional Uterine Bleeding","enrollment":48},{"nctId":"NCT01750476","phase":"","title":"Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives","status":"TERMINATED","sponsor":"Thomas Cherpes, DVM, MD","startDate":"2012-12","conditions":"Initiation of Oral Contraception (OC), Initiation of Depo-Provera (DMPA), Initiation of Mirena (LNG-IUD)","enrollment":7},{"nctId":"NCT00490555","phase":"PHASE2, PHASE3","title":"PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue","status":"COMPLETED","sponsor":"University of Washington","startDate":"2009-01","conditions":"Healthy","enrollment":32},{"nctId":"NCT01191203","phase":"NA","title":"Randomized Control Trial Copper Intrauterine Device and Depo-medroxyprogesterone Acetate (DMPA) of HIV+ Women in Malawi","status":"COMPLETED","sponsor":"Emory University","startDate":"2010-07","conditions":"HIV","enrollment":200},{"nctId":"NCT01791413","phase":"PHASE1, PHASE2","title":"Effect of Pre-operative Depo Medroxyprogesterone Acetate on Serum Anti-mullerian Hormone Level After Laparoscopic Ovarian Cystectomy of Endometriomas","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2012-03","conditions":"Endometriosis","enrollment":40},{"nctId":"NCT01143207","phase":"NA","title":"PK of Depo SubQ Injected in the Upper Arm","status":"COMPLETED","sponsor":"FHI 360","startDate":"2010-05","conditions":"Contraception","enrollment":26},{"nctId":"NCT00033358","phase":"PHASE2","title":"Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2002-02","conditions":"Endometrial Cancer","enrollment":52},{"nctId":"NCT00016601","phase":"NA","title":"Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2001-06","conditions":"HIV Infections","enrollment":76},{"nctId":"NCT00807625","phase":"PHASE2","title":"Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2008-11","conditions":"HIV, Contraception, HIV Infections","enrollment":66},{"nctId":"NCT00770887","phase":"","title":"Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2010-05","conditions":"Fertility","enrollment":50},{"nctId":"NCT00775047","phase":"NA","title":"Pharmacist-Administered Injections for Contraception","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2006-08","conditions":"Contraception","enrollment":50},{"nctId":"NCT00156650","phase":"PHASE1, PHASE2","title":"Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum","status":"COMPLETED","sponsor":"University of Washington","startDate":"2004-12","conditions":"Contraception","enrollment":23},{"nctId":"NCT00161447","phase":"PHASE1, PHASE2","title":"Male Hormonal Contraceptive Development-ACY-5","status":"COMPLETED","sponsor":"University of Washington","startDate":"2004-05","conditions":"Contraception","enrollment":43},{"nctId":"NCT00091728","phase":"","title":"Hormonal Contraception and Risk of Chlamydia and Gonorrhea","status":"TERMINATED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"1997-09","conditions":"Chlamydia Infection, Neisseriaceae Infection","enrollment":1200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":144,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["DMPA","Injectable contraception","Depo Provera"],"phase":"marketed","status":"active","brandName":"Depo Medroxyprogesterone acetate","genericName":"Depo Medroxyprogesterone acetate","companyName":"University of California, San Diego","companyId":"university-of-california-san-diego","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Depo-medroxyprogesterone acetate (DMPA) is a synthetic progestin that prevents pregnancy by suppressing ovulation and thickening cervical mucus. Used for Contraception (prevention of pregnancy), Management of endometriosis-related pain.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}